ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,701 | -11.4% | 173,196 | +0.4% | 0.02% | -10.7% |
| Q2 2023 | $5,304 | -12.3% | 172,554 | +2.8% | 0.03% | -17.6% |
| Q1 2023 | $6,048 | -8.3% | 167,869 | +0.6% | 0.03% | -15.0% |
| Q4 2022 | $6,593 | -99.9% | 166,819 | +2.8% | 0.04% | -7.0% |
| Q3 2022 | $6,522,000 | -0.1% | 162,319 | +4.5% | 0.04% | +4.9% |
| Q2 2022 | $6,528,000 | +39.8% | 155,289 | +29.6% | 0.04% | +57.7% |
| Q1 2022 | $4,668,000 | -4.3% | 119,823 | -2.1% | 0.03% | 0.0% |
| Q4 2021 | $4,879,000 | +10.4% | 122,433 | +0.1% | 0.03% | 0.0% |
| Q3 2021 | $4,420,000 | -4.7% | 122,303 | +8.0% | 0.03% | -3.7% |
| Q2 2021 | $4,640,000 | -9.6% | 113,194 | -3.7% | 0.03% | -15.6% |
| Q1 2021 | $5,130,000 | +156.2% | 117,604 | +194.0% | 0.03% | +146.2% |
| Q4 2020 | $2,002,000 | +52.4% | 40,004 | +28.1% | 0.01% | +30.0% |
| Q3 2020 | $1,314,000 | – | 31,240 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |